Smart healthcare: A prospective future medical approach for COVID-19.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Wolters Kluwer Health Country of Publication: Netherlands NLM ID: 101174817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1728-7731 (Electronic) Linking ISSN: 17264901 NLM ISO Abbreviation: J Chin Med Assoc Subsets: MEDLINE
    • Publication Information:
      Publication: 2019- : [Alphen aan den Rijn, The Netherlands] : Wolters Kluwer Health
      Original Publication: Taipei, Taiwan : Chinese Medical Association, c2003-
    • Subject Terms:
    • Abstract:
      COVID-19 has greatly affected human life for over 3 years. In this review, we focus on smart healthcare solutions that address major requirements for coping with the COVID-19 pandemic, including (1) the continuous monitoring of severe acute respiratory syndrome coronavirus 2, (2) patient stratification with distinct short-term outcomes (eg, mild or severe diseases) and long-term outcomes (eg, long COVID), and (3) adherence to medication and treatments for patients with COVID-19. Smart healthcare often utilizes medical artificial intelligence (AI) and cloud computing and integrates cutting-edge biological and optoelectronic techniques. These are valuable technologies for addressing the unmet needs in the management of COVID. By leveraging deep learning/machine learning capabilities and big data, medical AI can perform precise prognosis predictions and provide reliable suggestions for physicians' decision-making. Through the assistance of the Internet of Medical Things, which encompasses wearable devices, smartphone apps, internet-based drug delivery systems, and telemedicine technologies, the status of mild cases can be continuously monitored and medications provided at home without the need for hospital care. In cases that develop into severe cases, emergency feedback can be provided through the hospital for rapid treatment. Smart healthcare can possibly prevent the development of severe COVID-19 cases and therefore lower the burden on intensive care units.
      Competing Interests: Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.
      (Copyright © 2022, the Chinese Medical Association.)
    • References:
      Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579:265–9.
      Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020;583:459–68.
      Rahimi A, Mirzazadeh A, Tavakolpour S. Genetics and genomics of SARS-CoV-2: a review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection. Genomics 2020;113:1221–32.
      Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA 2020;117:11727–34.
      Chang TJ, Yang DM, Wang ML, Liang KH, Tsai PH, Chiou SH, et al. Genomic analysis and comparative multiple sequences of SARS-CoV2. J Chin Med Assoc 2020;83:537–43.
      Tsai PH, Wang ML, Yang DM, Liang KH, Chou SJ, Chiou SH, et al. Genomic variance of open reading frames (ORFs) and spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). J Chin Med Assoc 2020;83:725–32.
      Mlcochova P, Kemp SA, Dhar MS, Papa G, Meng B, Ferreira IATM, et al.; Indian SARS-CoV-2 Genomics Consortium (INSACOG). SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 2021;599:114–9.
      Hachmann NP, Miller J, Collier AY, Ventura JD, Yu J, Rowe M, et al. Neutralization escape by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4, and BA.5. N Engl J Med 2022;387:86–8.
      Gobeil SM, Henderson R, Stalls V, Janowska K, Huang X, May A, et al. Structural diversity of the SARS-CoV-2 Omicron spike. Mol Cell 2022;82:2050–2068.e6.
      Araf Y, Akter F, Tang YD, Fatemi R, Parvez MSA, Zheng C, et al. Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines. J Med Virol 2022;94:1825–32.
      Menni C, Valdes A, Polidori L, Antonelli M, Penamakuri S, Nogal A, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with sARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet 2022;399:1618–24.
      Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: common findings in COVID-19 patients. Laryngosc 2020;130:1787.
      Ma Q, Liu J, Liu Q, Kang L, Liu R, Jing W, et al. Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: a systematic review and meta-analysis. JAMA Netw Open 2021;4:e2137257.
      Yang DM, Chang TJ, Wang ML, Tsai PH, Lin TH, Wang CT, et al. Hunting severe acute respiratory syndrome coronavirus 2 (2019 novel coronavirus): from laboratory testing back to basic research. J Chin Med Assoc 2020;83:524–6.
      Liang KH, Chang TJ, Wang ML, Tsai PH, Lin TH, Wang CT, et al. Novel biosensor platforms for the detection of coronavirus infection and severe acute respiratory syndrome coronavirus 2. J Chin Med Assoc 2020;83:701–3.
      Tu YF, Chien CS, Yarmishyn AA, Lin YY, Luo YH, Lin YT, et al. A review of SARS-CoV-2 and the ongoing clinical trials. Int J Mol Sci 2020;21:2657.
      Liang KH, Hung KF, Wang ML, Chang TJ, Cheng YF, Chiang SH, et al. SARS-CoV-2 vaccines in children and adolescents: can immunization prevent hospitalization? J Chin Med Assoc 2022;85:891–5.
      Wu Q, Suo C, Brown T, Wang T, Teichmann SA, Bassett AR. INSIGHT: a population-scale COVID-19 testing strategy combining point-of-care diagnosis with centralized high-throughput sequencing. Sci Adv 2021;7:eabe5054.
      Singh P, Kaur R. An integrated fog and artificial intelligence smart health framework to predict and prevent COVID-19. Glob Transit 2020;2:283–92.
      Dwivedi R, Mehrotra D, Chandra S. Potential of internet of medical things (IoMT) applications in building a smart healthcare system: a systematic review. J Oral Biol Craniofac Res 2022;12:302–18.
      Rani SS, Selvakumar S, Pradeep Mohan Kumar K, Thanh Tai D, Dhiravida Chelvi E. Internet of medical things (IoMT) with machine learning–based COVID-19 diagnosis model using chest X-ray images. Data Sci for COVID-19 2021:627–41.
      Roy PK, Kumar A. Early prediction of COVID-19 using ensemble of transfer learning. Comput Electr Eng 2022;101:108018.
      Kollu PK, Kumar K, Kshirsagar PR, Islam S, Naveed QN, Hussain MR, et al. Development of advanced artificial intelligence and IoT automation in the crisis of COVID-19 detection. J Healthc Eng 2022;2022:1987917.
      Naik N, Hameed BMZ, Shetty DK, Swain D, Shah M, Paul R, et al. Legal and ethical consideration in artificial intelligence in healthcare: who takes responsibility? Front Surg 2022;9:862322.
      Ewuoso C, Hall S, Dierickx K. How do healthcare professionals respond to ethical challenges regarding information management? A review of empirical studies. Glob Bioeth 2021;32:67–84.
      Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med 2019;17:195.
      London AJ. Artificial intelligence in medicine: overcoming or recapitulating structural challenges to improving patient care? Cell Rep Med 2022;3:100622.
      Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J 2019;6:94–8.
      Yadav S, Kaushik A, Sharma S. Simplify the difficult: artificial intelligence and cloud computing in healthcare. In: Verma JK, Saxena D, González-Prida V, editors. IoT and Cloud Computing for Societal Good. EAI/Springer Innovations in Communication and Computing. Switzerland: Springer, Cham; 2022, p. 101–124. Available at https://doi.org/10.1007/978-3-030-73885-3_7 . Accessed July 21, 2022.
      Ahuja AS. The impact of artificial intelligence in medicine on the future role of the physician. PeerJ 2019;7:e7702.
      Dey D, Slomka PJ, Leeson P, Comaniciu D, Shrestha S, Sengupta PP, et al. Artificial intelligence in cardiovascular imaging: JACC state-of-the-art review. J Am Coll Cardiol 2019;73:1317–35.
      Pesapane F, Codari M, Sardanelli F. Artificial intelligence in medical imaging: threat or opportunity? radiologists again at the forefront of innovation in medicine. Eur Radiol Exp 2018;2:35.
      Murdoch B. Privacy and artificial intelligence: challenges for protecting health information in a new era. BMC Med Ethics 2021;22:122.
      Shneiderman Ben. Human-centered artificial intelligence: reliable, safe and trustworthy. arXiv.org (February 23, 2020). Available at https://arxiv.org/abs/2002.04087v2 . Accessed July 28, 2022.
      Huang KC, Huang CS, Su MY, Hung CL, Ethan Tu YC, Lin LC, et al. Artificial intelligence aids cardiac image quality assessment for improving precision in strain measurements. JACC Cardio Imag 2021;14:335–45.
      Suthar AB, Schubert S, Garon J, Couture A, Brown AM, Charania S. Coronavirus disease case definitions, diagnostic testing criteria, and surveillance in 25 countries with highest reported case counts. Emerg Infect Dis 2022;28:148–56.
      Iwasaki S, Fujisawa S, Nakakubo S, Kamada K, Yamashita Y, Fukumoto T, et al. Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva. J Infect 2020;81:e145–7.
      Esbin MN, Whitney ON, Chong S, Maurer A, Darzacq X, Tjian R. Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection. RNA 2020;26:771–83.
      Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020;25:2000045.
      Yu L, Wu S, Hao X, Dong X, Mao L, Pelechano V, et al. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform. Clin Chem 2020;66:975–7.
      Nouri R, Tang Z, Dong M, Liu T, Kshirsagar A, Guan W. CRISPR-based detection of SARS-CoV-2: a review from sample to result. Biosens Bioelectron 2021;178:113012.
      Mardian Y, Kosasih H, Karyana M, Neal A, Lau CY. Review of current COVID-19 diagnostics and opportunities for further development. Front Med 2021;8:615099.
      Habli Z, Saleh S, Zaraket H, Khraiche ML. COVID-19 in-vitro diagnostics: state-of-the-art and challenges for rapid, scalable, and high-accuracy screening. Front Bioeng Biotechnol 2021;8:605702.
      Rahimi H, Salehiabar M, Barsbay M, Ghaffarlou M, Kavetskyy T, Sharafi A, et al. CRISPR systems for COVID-19 diagnosis. ACS Sens 2021;6:1430–45.
      Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol 2021;19:171–83.
      Diao B, Wen K, Zhang J, Chen J, Han C, Chen Y, et al. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection. Clin Microbiol Infect 2021;27:289.e1–4.
      Colbert AJ, Lee DH, Clayton KN, Wereley ST, Linnes JC, Kinzer-Ursem TL. PD-LAMP smartphone detection of SARS-CoV-2 on chip. Anal Chim Acta 2022;1203:339702.
      Samacoits A, Nimsamer P, Mayuramart O, Chantaravisoot N, Sitthi-amorn P, Nakhakes C, et al. Machine learning-driven and smartphone-based fluorescence detection for CRISPR diagnostic of SARS-CoV-2. ACS Omega 2021;6:2727–33.
      Zhao H, Liu F, Xie W, Zhou TC, OuYang J, Jin L, et al. Ultrasensitive supersandwich-type electrochemical sensor for SARS-CoV-2 from the infected COVID-19 patients using a smartphone. Sens Actuators B Chem 2021;327:128899.
      Fabiani L, Mazzaracchio V, Moscone D, Fillo S, De Santis R, Monte A, et al. Paper-based immunoassay based on 96-well wax-printed paper plate combined with magnetic beads and colorimetric smartphone-assisted measure for reliable detection of SARS-CoV-2 in saliva. Biosens Bioelectron 2022;200:113909.
      Wang C, Wu Z, Liu B, Zhang P, Lu J, Li J, et al. Track-etched membrane microplate and smartphone immunosensing for SARS-CoV-2 neutralizing antibody. Biosens Bioelectron 2021;192:113550.
      Kawasaki D, Yamada H, Sueyoshi K, Hisamoto H, Endo T. Imprinted photonic crystal-film-based smartphone-compatible label-free optical sensor for SARS-CoV-2 testing. Biosen 2022;12:200.
      Soto F, Ozen MO, Guimarães CF, Wang J, Hokanson K, Ahmed R, et al. Wearable collector for noninvasive sampling of SARS-CoV-2 from exhaled breath for rapid detection. ACS Appl Mater Interf 2021;13:41445–53.
      Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021;19:141–54.
      Martín J, Tena N, Asuero AG. Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view. Microchem J 2021;167:106305.
      Dai WC, Zhang HW, Yu J, Xu HJ, Chen H, Luo SP, et al. CT imaging and differential diagnosis of COVID-19. Can Assoc Radiol J 2020;71:195–200.
      Nasser N, Emad-Ul-Haq Q, Imran M, Ali A, Razzak I, Al-Helali A. A smart healthcare framework for detection and monitoring of COVID-19 using IoT and cloud computing. Neural Comput Appl 2021;1–15.
      Mahanty C, Kumar R, Asteris PG, Gandomi AH. COVID-19 patient detection based on fusion of transfer learning and fuzzy ensemble models using CXR images. Appl Sci 2021;11:11423.
      Hassantabar S, Stefano N, Ghanakota V, Ferrari A, Nicola GN, Bruno R, et al. CovidDeep: SARS-CoV-2/COVID-19 test based on wearable medical sensors and efficient neural networks. IEEE Trans Cons Electr 2021;67:244–56.
      Mitratza M, Goodale BM, Shagadatova A, Kovacevic V, van de Wijgert J, Brakenhoff TB, et al. The performance of wearable sensors in the detection of SARS-CoV-2 infection: a systematic review. Lancet Digit Health 2022;4:e370–83.
      Lovey T, Bielecki M, Gültekin N, Stettbacher A, Muggli F, Stanga Z, et al. Illness tracking in SARS-CoV-2 tested persons using a smartphone app: a non-interventional, prospective, cohort study. New Micro New Infect 2022;46:100967.
      Wang M, Wu D, Liu C-H, Li Y, Hu J, Wang W, et al. Predicting progression to severe COVID-19 using the PAINT score. BMC Infect Dis 2022;22:498.
      Lee JY, Nam B-H, Kim M, Hwang J, Kim JY, Hyun M, et al. A risk scoring system to predict progression to severe pneumonia in patients with Covid-19. Sci Rep 2022;12:5390.
      Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021;38:101019.
      Bull-Otterson L, Baca S, Saydah S, Boehmer TK, Adjei S, Gray S, et al. Post–COVID conditions among adult COVID-19 survivors aged 18–64 and ≥65 years — United States, March 2020–November 2021. MMWR Morb Mortal Wkly Rep 2022;71:713–7.
      Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med 2021;27:626–31.
      Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al.; ISB-Swedish COVID-19 Biobanking Unit. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 2022;185:881–95.e20.
      Dos Santos WG. Natural history of COVID-19 and current knowledge on treatment therapeutic options. Biomed Pharmacother 2020;129:110493.
      Berenguer J, Borobia AM, Ryan P, Rodríguez-Baño J, Bellón JM, Jarrín I, et al.; COVID-19@Spain and COVID@HULP Study Groups. Development and validation of a prediction model for 30-day mortality in hospitalized patients with COVID-19: the COVID-19 SEIMC score. Thorax 2021;76:920–9.
      Ting DSW, Carin L, Dzau V, Wong TY. Digital technology and COVID-19. Nat Med 2020;26:459–61.
      Garrett PM, Wang YW, White JP, Kashima Y, Dennis S, Yang CT. High acceptance of COVID-19 tracing technologies in Taiwan: a nationally representative survey analysis. Int J Environ Res Public Health 2022;19:3323.
      Nguyen PQ, Soenksen LR, Donghia NM, Angenent-Mari NM, de Puig H, Huang A, et al. Wearable materials with embedded synthetic biology sensors for biomolecule detection. Nat Biotechnol 2021;39:1366–74.
      Shen YT, Chen L, Yue WW, Xu HX. Digital technology-based telemedicine for the COVID-19 pandemic. Front Med 2021;8:646506.
      Mishra T, Wang M, Metwally AA, Bogu GK, Brooks AW, Bahmani A, et al. Pre-symptomatic detection of COVID-19 from smartwatch data. Nat Biomed Eng 2020;4:1208–20.
      Quer G, Radin JM, Gadaleta M, Baca-Motes K, Ariniello L, Ramos E, et al. Wearable sensor data and self-reported symptoms for COVID-19 detection. Nat Med 2021;27:73–7.
      Natarajan A, Su HW, Heneghan C. Assessment of physiological signs associated with COVID-19 measured using wearable devices. NPJ Digit Med 2020;3:156.
      Smarr BL, Aschbacher K, Fisher SM, Chowdhary A, Dilchert S, Puldon K, et al. Feasibility of continuous fever monitoring using wearable devices. Sci Rep 2020;10:21640.
      Miller DJ, Capodilupo JV, Lastella M, Sargent C, Roach GD, Lee VH, et al. Analyzing changes in respiratory rate to predict the risk of COVID-19 infection. PLoS One 2020;15:e0243683.
    • Publication Date:
      Date Created: 20221013 Date Completed: 20230120 Latest Revision: 20230403
    • Publication Date:
      20240628
    • Accession Number:
      PMC9847685
    • Accession Number:
      10.1097/JCMA.0000000000000824
    • Accession Number:
      36227021